Pharmaceutical industry results preview: Sun Pharma, Dr Reddy's, Lupin, others ...

13-01-2014 Financial ExpressComments (0)


The US generics segment remains the key earnings growth driver. Dr Reddy's, Sun Pharma and Lupin have been beneficiaries of high-value launches in the recent past. The currency environment remained favourable with reduced volatility during the quarter ...

Read more on Financial Express

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top